461 related articles for article (PubMed ID: 10992443)
1. Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease.
Sambol SP; Merrigan MM; Lyerly D; Gerding DN; Johnson S
Infect Immun; 2000 Oct; 68(10):5480-7. PubMed ID: 10992443
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France.
Barbut F; Lalande V; Burghoffer B; Thien HV; Grimprel E; Petit JC
J Clin Microbiol; 2002 Jun; 40(6):2079-83. PubMed ID: 12037068
[TBL] [Abstract][Full Text] [Related]
3. International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants.
Johnson S; Sambol SP; Brazier JS; Delmée M; Avesani V; Merrigan MM; Gerding DN
J Clin Microbiol; 2003 Apr; 41(4):1543-7. PubMed ID: 12682143
[TBL] [Abstract][Full Text] [Related]
4. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile.
Lemee L; Dhalluin A; Testelin S; Mattrat MA; Maillard K; Lemeland JF; Pons JL
J Clin Microbiol; 2004 Dec; 42(12):5710-4. PubMed ID: 15583303
[TBL] [Abstract][Full Text] [Related]
5. Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection.
Shin BM; Kuak EY; Lee EJ; Songer JG
J Clin Microbiol; 2009 Sep; 47(9):2952-6. PubMed ID: 19625481
[TBL] [Abstract][Full Text] [Related]
6. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.
Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL
Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481
[TBL] [Abstract][Full Text] [Related]
7. tcdA As a diagnostic target in a loop-mediated amplification assay for detecting toxigenic Clostridium difficile.
Couturier B; Schlaberg R; Konzak C; Nicholes J; Law C; She RC
J Clin Lab Anal; 2013 May; 27(3):171-6. PubMed ID: 23686774
[TBL] [Abstract][Full Text] [Related]
8. Pseudomembranous colitis caused by toxin A-negative/toxin B-positive variant strain of Clostridium difficile.
Toyokawa M; Ueda A; Tsukamoto H; Nishi I; Horikawa M; Sunada A; Asari S
J Infect Chemother; 2003 Dec; 9(4):351-4. PubMed ID: 14691659
[TBL] [Abstract][Full Text] [Related]
9. Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea.
Shin BM; Kuak EY; Yoo SJ; Shin WC; Yoo HM
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):333-7. PubMed ID: 18082994
[TBL] [Abstract][Full Text] [Related]
10. Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area.
Shin BM; Lee EJ; Kuak EY; Yoo SJ
Anaerobe; 2009 Dec; 15(6):266-9. PubMed ID: 19772927
[TBL] [Abstract][Full Text] [Related]
11. Phylogenomics of 8,839 Clostridioides difficile genomes reveals recombination-driven evolution and diversification of toxin A and B.
Mansfield MJ; Tremblay BJ; Zeng J; Wei X; Hodgins H; Worley J; Bry L; Dong M; Doxey AC
PLoS Pathog; 2020 Dec; 16(12):e1009181. PubMed ID: 33370413
[TBL] [Abstract][Full Text] [Related]
12. Comparative genomics of
Janezic S; Dingle K; Alvin J; Accetto T; Didelot X; Crook DW; Lacy DB; Rupnik M
Microb Genom; 2020 Oct; 6(10):. PubMed ID: 33030421
[No Abstract] [Full Text] [Related]
13. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates.
Spigaglia P; Mastrantonio P
J Clin Microbiol; 2002 Sep; 40(9):3470-5. PubMed ID: 12202595
[TBL] [Abstract][Full Text] [Related]
14. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.
Merrigan M; Venugopal A; Mallozzi M; Roxas B; Viswanathan VK; Johnson S; Gerding DN; Vedantam G
J Bacteriol; 2010 Oct; 192(19):4904-11. PubMed ID: 20675495
[TBL] [Abstract][Full Text] [Related]
15. Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile.
Borriello SP; Wren BW; Hyde S; Seddon SV; Sibbons P; Krishna MM; Tabaqchali S; Manek S; Price AB
Infect Immun; 1992 Oct; 60(10):4192-9. PubMed ID: 1398930
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
[TBL] [Abstract][Full Text] [Related]
17. Association between Clostridioides difficile ribotypes, restriction endonuclease analysis types, and toxin gene expression.
Watanabe H; Koizumi Y; Matsumoto A; Asai N; Yamagishi Y; Mikamo H
Anaerobe; 2018 Dec; 54():140-143. PubMed ID: 30201540
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the pathogenicity locus in Clostridium difficile strains.
Cohen SH; Tang YJ; Silva J
J Infect Dis; 2000 Feb; 181(2):659-63. PubMed ID: 10669352
[TBL] [Abstract][Full Text] [Related]
19. Detection and transcription of toxin DNA in a nontoxigenic strain of Clostridium difficile.
Mathis JN; Pilkinton L; McMillin DE
Curr Microbiol; 1999 Jun; 38(6):324-8. PubMed ID: 10341072
[TBL] [Abstract][Full Text] [Related]
20. Laboratory diagnosis of toxigenic Clostridium difficile by polymerase chain reaction: presence of toxin genes and their stable expression in toxigenic isolates from Japanese individuals.
Karasawa T; Nojiri T; Hayashi Y; Maegawa T; Yamakawa K; Wang XM; Nakamura S
J Gastroenterol; 1999 Feb; 34(1):41-5. PubMed ID: 10204609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
